000 01249 a2200337 4500
005 20250514191520.0
264 0 _c20040810
008 200408s 0 0 eng d
022 _a0022-1759
024 7 _a10.1016/j.jim.2004.01.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHudgens, Michael G
245 0 0 _aStatistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.
_h[electronic resource]
260 _bJournal of immunological methods
_cMay 2004
300 _a19-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAIDS Serodiagnosis
_xmethods
650 0 4 _aAIDS Vaccines
_ximmunology
650 0 4 _aData Interpretation, Statistical
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aHIV Antibodies
_xanalysis
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHumans
700 1 _aSelf, Steven G
700 1 _aChiu, Ya-Lin
700 1 _aRussell, Nina D
700 1 _aHorton, Helen
700 1 _aMcElrath, M Juliana
773 0 _tJournal of immunological methods
_gvol. 288
_gno. 1-2
_gp. 19-34
856 4 0 _uhttps://doi.org/10.1016/j.jim.2004.01.018
_zAvailable from publisher's website
999 _c14890363
_d14890363